UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.023

Sortiert nach

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

Journal of clinical oncology, 2010-10, Vol.28 (29), p.4450-4456

2010

Link zum Volltext

Verfügbarkeit prüfen

Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation

Current pharmaceutical design, 2012-12, Vol.18 (37), p.6043

2012

Link zum Volltext

Verfügbarkeit prüfen

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

The lancet oncology, 2017-05, Vol.18 (5), p.599-610

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial

The lancet oncology, 2017-05, Vol.18 (5), p.623-630

2017

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1378-1388

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Journal of clinical oncology, 2013-02, Vol.31 (5), p.616-622

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Journal of the American Academy of Dermatology, 2017-08, Vol.77 (2), p.310-317.e1

2017

Link zum Volltext

Verfügbarkeit prüfen

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4189-4198

2011

Link zum Volltext

Verfügbarkeit prüfen

Severe Spruelike Enteropathy Associated With Olmesartan

Mayo Clinic proceedings, 2012-08, Vol.87 (8), p.732-738

2012

Link zum Volltext

Verfügbarkeit prüfen

Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease

Chest, 2015-08, Vol.148 (2), p.499-506

2015

Link zum Volltext

Verfügbarkeit prüfen

Nausea and Vomiting in 2021: A Comprehensive Update

Journal of clinical gastroenterology, 2021-04, Vol.55 (4), p.279

2021

Link zum Volltext

Verfügbarkeit prüfen

Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis

Journal of clinical oncology, 2015-11, Vol.33 (32), p.3759-3765

2015

Link zum Volltext

Verfügbarkeit prüfen

Determination of glyphosate and AMPA in blood and urine from humans: About 13 cases of acute intoxication

Forensic science international, 2013-03, Vol.226 (1), p.e20-e25

2013

Link zum Volltext

Verfügbarkeit prüfen

A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms

Journal of affective disorders, 2016-12, Vol.206, p.140-150

2016

Link zum Volltext

Verfügbarkeit prüfen

Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed

Current medical research and opinion, 2006-12, Vol.22 (12), p.2403-2410

2006

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

European journal of cancer (1990), 2017-05, Vol.76, p.144-151

2017

Link zum Volltext

Verfügbarkeit prüfen

Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review

Critical reviews in food science and nutrition, 2017-01, Vol.57 (1), p.141-146

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety of Semaglutide

Frontiers in endocrinology (Lausanne), 2021-07, Vol.12, p.645563

2021

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Annals of oncology, 2014-07, Vol.25 (7), p.1328-1333

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review

Critical reviews in oncology/hematology, 2016-03, Vol.99, p.13-36

2016

Link zum Volltext

Verfügbarkeit prüfen

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

Journal of clinical oncology, 2010-10, Vol.28 (29), p.4485-4491

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma

European urology, 2016-02, Vol.69 (2), p.345-351

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study

Annals of oncology, 2014-07, Vol.25 (7), p.1340-1346

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5410-5417

2009

Link zum Volltext

Verfügbarkeit prüfen

Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial

Journal of clinical oncology, 2020-09, Vol.38 (27), p.3129-3137

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.023

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.962)
Mit Volltextzugriff
(1.499)

Publikationsform

Artikel
(2.021)
magazinearticle
(2)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.984)
Nausea - Chemically Induced
(1.647)
Science & Technology
(1.507)
Female
(1.501)
Life Sciences & Biomedicine
(1.477)
Male
(1.236)
Middle Aged
(1.220)
Adult
(1.141)
Aged
(951)
Vomiting - Chemically Induced
(950)
Biological And Medical Sciences
(676)
Medical Sciences
(661)
Oncology
(485)
Pharmacology. Drug Treatments
(447)
Drug Administration Schedule
(382)
Antineoplastic Agents - Adverse Effects
(369)
Treatment Outcome
(357)
Double-Blind Method
(341)
Nausea - Prevention & Control
(306)
Anesthesiology
(303)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gan To Kagaku Ryoho
(303)
Journal Of Clinical Oncology
(197)
Anesthesia And Analgesia
(124)
American Journal Of Clinical Oncology
(97)
Anesthesiology
(50)
European Journal Of Anaesthesiology
(46)
Anti-Cancer Drugs
(44)
Current Medical Research And Opinion
(37)
Medicine
(35)
European Journal Of Cancer
(27)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Severe Spruelike Enteropathy Associated With Olmesartan

Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease

Nausea and Vomiting in 2021: A Comprehensive Update

Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis

Determination of glyphosate and AMPA in blood and urine from humans: About 13 cases of acute intoxication

A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms

Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review

Safety of Semaglutide

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial

Aktive Filter

Suchergebnisse filtern